Merck&Co earnings beat by $0.07, revenue topped estimates

Merck&Co (NYSE: MRK ) reported third quarter EPS of $1.57, $0.07 better than the analyst estimate of $1.50. Revenue for the quarter came in at $16.66B versus the consensus estimate of $16.45B. Guidance

Merck&Co sees FY 2024 EPS of $7.72-$7.77 versus the analyst consensus of $7.74.

Merck&Co sees FY 2024 revenue of $63.60B-$64.10B versus the analyst consensus of $64.15B.





Merck&Co's stock price closed at $104.83. It is down -9.00% in the last 3 months and up 1.93% in the last 12 months.

Merck&Co saw 0 positive EPS revisions and 16 negative EPS revisions in the last 90 days. See Merck&Co's stock price’s past reactions to earnings here.

According to InvestingPro, Merck&Co's Financial Health score is "great performance".

Check out Merck&Co's recent earnings performance , and Merck&Co's financials here.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Source: Investing.com